Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

α-ketoglutarate accumulation orchestrates immunosuppressive metabolic remodeling to drive cetuximab resistance in metastatic colorectal cancer.

Cell death & disease·2026
Same author

Correction to "Development of a Fluorescence Polarization Assay for p300/CBP and Its Application Using a Direct-to-Biology Approach".

Analytical chemistry·2026
Same author

Progress in Natural Products Target Discovery Technology.

MedComm·2026
Same author

Naïve pluripotency and genomic stability are coordinated in embryonic stem cells by a novel pluripotency regulator ZFP998.

Nucleic acids research·2026
Same author

Integrated Strategic Design and In Situ Click Chemistry Approach to Rapid Discovery of Novel Potent Covalent TEAD Inhibitors.

Journal of medicinal chemistry·2026
Same author

Development of a Fluorescence Polarization Assay for p300/CBP and Its Application Using a Direct-to-Biology Approach.

Analytical chemistry·2026

Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.4K

Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3.

Yuying Suo1,2, Daohai Du3, Chao Chen4,5,6

  • 1University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, P. R. China.

Journal of Medicinal Chemistry
|March 11, 2024
PubMed
Summary

Proteolysis-targeting chimera (PROTAC) technology degrades target proteins. This study identifies STAT1 as a biomarker for STAT3 PROTAC degrader efficacy in leukemia and lymphoma.

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

3.6K
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K

Related Experiment Videos

Last Updated: Jul 1, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.4K
Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

3.6K
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Proteomics

Background:

  • Proteolysis-targeting chimera (PROTAC) technology offers a novel approach for targeted protein degradation.
  • Heterogeneous drug responses pose challenges in understanding PROTAC mechanisms and predicting efficacy.
  • Identifying reliable biomarkers is crucial for optimizing PROTAC-based therapies.

Purpose of the Study:

  • To comprehensively profile the multidimensional pharmacodynamic response of a STAT3 PROTAC degrader.
  • To explore PROTAC drug sensitivity and identify potential biomarkers.
  • To validate the identified biomarker in relevant preclinical models.

Main Methods:

  • Utilized data-independent acquisition-based mass spectrometry for multidimensional proteome profiling of PROTACs (DIA-MPP).
  • Applied DIA-MPP to profile a STAT3 PROTAC degrader across six leukemia and lymphoma cell lines under various conditions.
  • Validated the identified biomarker in cell lines, patient-derived organoids, and mouse models.

Main Results:

  • Demonstrated the pharmacodynamic properties and downstream biological responses of the STAT3 PROTAC degrader.
  • Revealed STAT1 as a potential biomarker for STAT3 PROTAC degrader sensitivity by comparing sensitive and insensitive cell lines.
  • Successfully validated the STAT1 biomarker in diverse preclinical settings.

Conclusions:

  • The study establishes a comprehensive framework for describing multidimensional PROTAC pharmacodynamic responses.
  • STAT1 is identified as a validated biomarker for STAT3 PROTAC degrader sensitivity.
  • This work provides a valuable example for biomarker exploration in PROTAC drug development.